Review of the CHA₂DS₂-VASc Score
Evidence to Action: Official Journal of MDCalc · 15.04.2026 · 022026 (01)
DOI: 10.65357/001c.160263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence to Action: Official Journal of MDCalc, online erschienen am 15.04.2026. Verfasst von Rahul Aggarwal.
Abstract (Originalsprache)
The CHA₂DS₂-VASc score is a validated clinical tool for estimating the annual risk of thromboembolic and ischemic stroke in patients with non-valvular atrial fibrillation. It was developed among patients not taking anticoagulation. It refines the earlier CHADS₂ score by incorporating additional risk factors to identify low-risk patients who may not require anticoagulation. The score guides shared decision-making regarding oral anticoagulation.
Zitieren
APA
Aggarwal, R. (2026). Review of the CHA₂DS₂-VASc Score. Evidence to Action: Official Journal of MDCalc, 022026(01). https://doi.org/10.65357/001c.160263
Vancouver
Aggarwal R. Review of the CHA₂DS₂-VASc Score. Evidence to Action: Official Journal of MDCalc. 2026;022026(01). doi:10.65357/001c.160263
BibTeX
@article{Aggarwal2026,
author = {Aggarwal, Rahul},
title = {Review of the CHA₂DS₂-VASc Score},
journal = {Evidence to Action: Official Journal of MDCalc},
year = {2026},
volume = {022026},
number = {01},
doi = {10.65357/001c.160263}
}
EUVIMED